{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:34:53Z","timestamp":1787924093866,"version":"build-2784847793"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1A2C2012917"],"award-info":[{"award-number":["NRF-2020R1A2C2012917"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003718","name":"Korea Institute of Oriental Medicine","doi-asserted-by":"publisher","award":["KSN1515293"],"award-info":[{"award-number":["KSN1515293"]}],"id":[{"id":"10.13039\/501100003718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003718","name":"Korea Institute of Oriental Medicine","doi-asserted-by":"publisher","award":["KSN2411012"],"award-info":[{"award-number":["KSN2411012"]}],"id":[{"id":"10.13039\/501100003718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.biopha.2024.117671","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T21:47:47Z","timestamp":1731361667000},"page":"117671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Neuroprotective effects of Elaeagnus glabra f. oxyphylla extract in amyloid-beta-induced cognitive deficit mice: Involvement of the PKC-delta, MYL2, and FER pathways"],"prefix":"10.1016","volume":"181","author":[{"given":"Eunjin","family":"Sohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0727-3864","authenticated-orcid":false,"given":"Hye-Sun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5949-2407","authenticated-orcid":false,"given":"Bu-Yeo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5152-9439","authenticated-orcid":false,"given":"Yu Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6529-1767","authenticated-orcid":false,"given":"Soo-Jin","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117671_bib1","unstructured":"World Health Organization, Dementia fact sheet, 2023. \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia\u3009."},{"key":"10.1016\/j.biopha.2024.117671_bib2","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on Alzheimer\u2019s disease: Causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules."},{"key":"10.1016\/j.biopha.2024.117671_bib3","article-title":"Erratum: Alzheimer\u2019s disease drug development pipeline: 2023","volume":"9","author":"Cummings","year":"2023","journal-title":"Alzheimers Dement. (N. Y)"},{"key":"10.1016\/j.biopha.2024.117671_bib4","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.12688\/f1000research.14506.1","article-title":"Current understanding of Alzheimer\u2019s disease diagnosis and treatment","volume":"7","author":"Weller","year":"2018","journal-title":"F1000Res."},{"key":"10.1016\/j.biopha.2024.117671_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","article-title":"Anti-amyloid monoclonal antibodies for the treatment of Alzheimer\u2019s disease","volume":"38","author":"Cummings","year":"2024","journal-title":"BioDrugs."},{"key":"10.1016\/j.biopha.2024.117671_bib6","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1111\/cns.14234","article-title":"Therapeutic potential of aromatic plant extracts in Alzheimer\u2019s disease: comprehensive review of their underlying mechanisms","volume":"29","author":"Ma","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biopha.2024.117671_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/1871527320666210920120612","article-title":"Phytotherapeutics against Alzheimer\u2019s disease: mechanism, molecular targets and challenges for drug development","volume":"21","author":"Gayathri","year":"2022","journal-title":"CNS Neurol. Disord. Drug Targets."},{"key":"10.1016\/j.biopha.2024.117671_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116373","article-title":"Phytochemicals targeting Alzheimer's disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action","volume":"173","author":"Zhao","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2024.117671_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116376","article-title":"Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer's disease","volume":"174","author":"Albadrani","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.117671_bib10","unstructured":"National Institute of Biological Resources, National Biodiversity Database. \u3008http:\/\/species.nibr.go.kr\u3009. (accessed 10 June 2020)."},{"key":"10.1016\/j.biopha.2024.117671_bib11","first-page":"559","article-title":"Methanol extract of Elaeagnus glabra, a Korean medicinal plant, inhibits HT1080 tumor cell invasion","volume":"21","author":"Li","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2024.117671_bib12","first-page":"2943","article-title":"Chemical constituents with anti-lipid droplet accumulation and anti-inflammatory activity from Elaeagnus glabra","volume":"12","author":"Cheng","year":"2023","journal-title":"Plants (Basel)."},{"key":"10.1016\/j.biopha.2024.117671_bib13","first-page":"139","article-title":"Antibacterial activity of flavonoids against Staphylococcus epidermidis, a skin bacterium","volume":"51","author":"Nishino","year":"1987","journal-title":"Agric. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.117671_bib14","first-page":"1","article-title":"Ethanol extract of Elaeagnus glabra f. oxyphylla branches alleviates the inflammatory response through suppression of cyclin D3\/cyclin-dependent kinase 11p58 coupled to lipopolysaccharide-activated BV-2 microglia","volume":"17","author":"Lim","year":"2022","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.biopha.2024.117671_bib15","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3390\/nu11061205","article-title":"Elaeagnus glabra f. oxyphylla attenuates scopolamine-induced learning and memory impairments in mice by improving cholinergic transmission via activation of CREB\/NGF signaling","volume":"11","author":"Sohn","year":"2019","journal-title":"Nutrients."},{"key":"10.1016\/j.biopha.2024.117671_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/157015906776359577","article-title":"Neuronal cell death in Alzheimer\u2019s disease and a neuroprotective factor, humanin","volume":"4","author":"Niikura","year":"2006","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2024.117671_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.biopha.2024.117671_bib18","first-page":"1","article-title":"Interpretation of animal dose and human equivalent dose for drug development","volume":"31","author":"Shin","year":"2010","journal-title":"J. Kor. Orient. Med."},{"key":"10.1016\/j.biopha.2024.117671_bib19","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.1021\/bi300113x","article-title":"Morin inhibits the early stages of amyloid \u03b2-peptide aggregation by altering tertiary and quaternary interactions to produce \u201coff-pathway\u201d structures","volume":"51","author":"Lemkul","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2024.117671_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174506","article-title":"Morin attenuates memory deficits in a rat model of Alzheimer's disease by ameliorating oxidative stress and neuroinflammation","volume":"910","author":"Mohammadi","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"109","key":"10.1016\/j.biopha.2024.117671_bib21","first-page":"53308","article-title":"Intracerebroventricular injection of amyloid-\u03b2 peptides in normal mice to acutely induce Alzheimer-like cognitive deficits","author":"Kim","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biopha.2024.117671_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02244409","article-title":"Effects of NMDA receptor antagonists on passive avoidance learning and retrieval in rats and mice","volume":"100","author":"Venable","year":"1990","journal-title":"Psychopharmacology."},{"key":"10.1016\/j.biopha.2024.117671_bib23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/297681a0","article-title":"Place navigation impaired in rats with hippocampal lesions","volume":"297","author":"Morris","year":"1982","journal-title":"Nature."},{"key":"10.1016\/j.biopha.2024.117671_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuroscience.2024.08.029","article-title":"Exploring the therapeutic potential of Potentilla fragarioides var. major (Rosaceae) extract in Alzheimer\u2019s disease using in vitro and in vivo models: a multi-faceted approach","volume":"559","author":"Sohn","year":"2024","journal-title":"Neuroscience."},{"key":"10.1016\/j.biopha.2024.117671_bib25","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0039-9140(97)00017-9","article-title":"A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability","volume":"44","author":"Ishiyama","year":"1997","journal-title":"Talanta."},{"key":"10.1016\/j.biopha.2024.117671_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0022-1759(83)90438-6","article-title":"An enzyme-release assay for natural cytotoxicity","volume":"64","author":"Korzeniewski","year":"1983","journal-title":"J. Immunol. Methods."},{"key":"10.1016\/j.biopha.2024.117671_bib27","first-page":"255","article-title":"Antibody arrays in biomarker discovery, Adv","volume":"69","author":"Wilson","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.biopha.2024.117671_bib28","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/bioinformatics\/bth078","article-title":"Open source clustering software","volume":"20","author":"de Hoon","year":"2004","journal-title":"Bioinformatics."},{"key":"10.1016\/j.biopha.2024.117671_bib29","doi-asserted-by":"crossref","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.biopha.2024.117671_bib30","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: A cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics."},{"key":"10.1016\/j.biopha.2024.117671_bib31","first-page":"1381","article-title":"Neuroprotective effect of resveratrol against scopolamine-induced cognitive impairment and oxidative stress in rats, Arch","volume":"65","author":"Bunadri","year":"2013","journal-title":"Biol. Sci."},{"key":"10.1016\/j.biopha.2024.117671_bib32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science."},{"key":"10.1016\/j.biopha.2024.117671_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer\u2019s disease","volume":"12","author":"Kametani","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2024.117671_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","article-title":"History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease","volume":"4","author":"Liu","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2024.117671_bib35","unstructured":"U.S. Food & Drug Administration, Drug approval package: Aduhelm (aducanumab-avwa). Office of Neurology\u2019s summary review memorandum. \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2021\/Aducanumab_BLA761178_Dunn_2021_06_07.pdf\u3009."},{"key":"10.1016\/j.biopha.2024.117671_bib36","unstructured":"U.S. Food and Drug Administration, Drug approval package: Leqembi (lecanemab-irmb). Office of Neurology\u2019s summary review memorandum. \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2024\/761269Orig1s001.pdf\u3009."},{"key":"10.1016\/j.biopha.2024.117671_bib37","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.3390\/molecules25214917","article-title":"Catechol-type flavonoids from the branches of Elaeagnus glabra f. oxyphylla exert antioxidant activity and an inhibitory effect on amyloid-\u03b2 aggregation","volume":"25","author":"Kim","year":"2020","journal-title":"Molecules."},{"key":"10.1016\/j.biopha.2024.117671_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ame2.12313","article-title":"Cellular response to \u03b2-amyloid neurotoxicity in Alzheimer\u2019s disease and implications in new therapeutics","volume":"6","author":"Zhang","year":"2023","journal-title":"Anim. Model Exp. Med."},{"key":"10.1016\/j.biopha.2024.117671_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2024.117671_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112512","article-title":"The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of amyloid beta (a\u03b2) peptide","volume":"383","author":"Shekarian","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2024.117671_bib41","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2024.117671_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2021.113652","article-title":"A review of behavioral methods for the evaluation of cognitive performance in animal models: current techniques and links to human cognition","volume":"244","author":"Ghafarimoghadam","year":"2022","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2024.117671_bib43","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/44.10.8813082","article-title":"NeuN: a useful neuronal marker for diagnostic histopathology","volume":"44","author":"Wolf","year":"1996","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.biopha.2024.117671_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.semcancer.2017.04.012","article-title":"Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression","volume":"48","author":"Isakov","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biopha.2024.117671_bib45","doi-asserted-by":"crossref","first-page":"575","DOI":"10.31083\/ph.2016.6660","article-title":"Anti-neuroinflammation activity of acetylpuerarin mediated by a PKC-\u03b4-dependent caspase signaling pathway: in vivo and in vitro studies","volume":"71","author":"Cai","year":"2016","journal-title":"Pharmazie."},{"key":"10.1016\/j.biopha.2024.117671_bib46","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neurobiolaging.2007.07.011","article-title":"A\u03b21\u201342 stimulated T cells express P-PKC-\u03b4 and P-PKC-\u03b6 in Alzheimer disease","volume":"30","author":"Miscia","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biopha.2024.117671_bib47","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0197-0186(00)00126-1","article-title":"Amyloid beta protein activates PKC-delta and induces translocation of myristoylated alanine-rich C kinase substrate (MARCKS) in microglia","volume":"38","author":"Nakai","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2024.117671_bib48","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1084\/jem.20171193","article-title":"Inhibition of PKC\u03b4 reduces amyloid-\u03b2 levels and reverses Alzheimer disease phenotypes","volume":"215","author":"Du","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2024.117671_bib49","doi-asserted-by":"crossref","first-page":"13446","DOI":"10.1074\/jbc.M113.455444","article-title":"Myosin regulatory light chain (RLC) phosphorylation change as a modulator of cardiac muscle contraction in disease","volume":"288","author":"Toepfer","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.117671_bib50","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/ar.24238","article-title":"The E3 ubiquitin ligase March8 regulates TNF-\u03b1-induced apoptosis in hippocampal neurons by targeting myosin light chain 2 for degradation","volume":"302","author":"Guo","year":"2019","journal-title":"Anat. Rec. (Hoboken)."},{"key":"10.1016\/j.biopha.2024.117671_bib51","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1096\/fj.13-243691","article-title":"Amyloid \u03b2 peptide stimulates platelet activation through RhoA-dependent modulation of actomyosin organization","volume":"28","author":"Sonkar","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2024.117671_bib52","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1242\/jcs.01174","article-title":"Continuous association of cadherin with beta-catenin requires the non-receptor tyrosine-kinase fer","volume":"117","author":"Xu","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.biopha.2024.117671_bib53","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1128\/MCB.23.7.2287-2297.2003","article-title":"p120 catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction","volume":"23","author":"Piedra","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2024.117671_bib54","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1083\/jcb.200807188","article-title":"Synapses are regulated by the cytoplasmic tyrosine kinase Fer in a pathway mediated by p120catenin, Fer, SHP-2, and beta-catenin","volume":"183","author":"Lee","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2024.117671_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41420-023-01324-1","article-title":"Neuroprotective effect of astragalin via activating PI3K\/Akt-mTOR-mediated autophagy on APP\/PS1 mice","volume":"9","author":"Yang","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biopha.2024.117671_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153664","article-title":"Natural products attenuate PI3K\/Akt\/mTOR signaling pathway: a promising strategy in regulating neurodegeneration","volume":"91","author":"Fakhri","year":"2021","journal-title":"Phytomedicine."},{"key":"10.1016\/j.biopha.2024.117671_bib57","article-title":"Ameliorating activity of Ishige okamurae on the amyloid beta-induced cognitive deficits and neurotoxicity through regulating ERK, p38 MAPK, and JNK signaling in Alzheimer\u2019s disease-like mice model","volume":"64","author":"Kwon","year":"2020","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.biopha.2024.117671_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2020.103551","article-title":"P38K and JNK pathways are induced by amyloid-\u03b2 in astrocyte: implication of MAPK pathways in astrogliosis in Alzheimer\u2019s disease","volume":"108","author":"Saha","year":"2020","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.biopha.2024.117671_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/CS20160044","article-title":"Neurotrophin signalling: Novel insights into mechanisms and pathophysiology","volume":"131","author":"Mitre","year":"2017","journal-title":"Clin. Sci. (Lond.)."},{"key":"10.1016\/j.biopha.2024.117671_bib60","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/md19110587","article-title":"\u03c9-3 DPA protected neurons from neuroinflammation by balancing microglia M1\/M2 polarizations through inhibiting NF-\u03baB\/MAPK p38 signaling and activating neuron-BDNF-PI3K\/AKT pathways","volume":"19","author":"Liu","year":"2021","journal-title":"Mar. Drugs."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224015579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224015579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:13:22Z","timestamp":1787922802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224015579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":60,"alternative-id":["S0753332224015579"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117671","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effects of Elaeagnus glabra f. oxyphylla extract in amyloid-beta-induced cognitive deficit mice: Involvement of the PKC-delta, MYL2, and FER pathways","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117671"}}